New MRI technique eyes lung disease in infants

Article

Diffusion hyperpolarized helium-3 MRI could provide a noninvasive means to diagnose and manage children with bronchopulmonary dysplasia, according to researchers in Philadelphia and Virginia.

Diffusion hyperpolarized helium-3 MRI could provide a noninvasive means to diagnose and manage children with bronchopulmonary dysplasia, according to researchers in Philadelphia and Virginia.

Bronchopulmonary dysplasia (BPD) affects preterm infants whose lungs start performing the vital gas exchange before their alveoli are fully developed, resulting in inflammation, injury, and deficient lung development. Physicians currently lack the data and means to properly diagnose the condition or assess treatment response.

A multicenter group led by Dr. Jaime F. Mata, a lecturer in radiology at the University of Virginia Health Sciences Center, enrolled 32 healthy subjects with a history of full-term birth and 13 with a history of preterm birth complicated by subsequent BPD. All subjects underwent diffusion MRI at 1.5T during a breath-hold following inhalation of hyperpolarized He-3 gas and spirometry. The investigators performed apparent diffusion coefficient (ADC) mapping for lung volume quantitation.

They found children with a history of preterm birth and BPD had elevated ADC values and the same or slightly lower lung volumes compared with age-matched healthy control subjects. Study findings, which were presented at the 2006 ISMRM meeting, confirmed histological data showing that children with BPD have larger but fewer alveoli.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.